<DOC>
	<DOCNO>NCT02133898</DOCNO>
	<brief_summary>This open-label study assess efficacy l-methylfolate monotherapy patient mild moderate major depressive disorder ( MDD ) . The plan enroll 75 patient mild moderate MDD base Structured Clinical Interview DSM-IV ( SCID ) Hamilton Depression Rating Scale-24 ( HDRS-24 ) score 8-24 . The investigator collect genotype data methylenetetrahydrofolate Reductase ( MTHFR ) , MTR MTRR patient population . Subjects able receive genotype result , request , upon completion study . The investigator hypothesize depressed patient likely mutation MTHFR gene</brief_summary>
	<brief_title>The Use Of L-Methylfolate As A Treatment For Depression</brief_title>
	<detailed_description>Participation study consist follow visit test : Screening Visit include interviewed staff member determine qualification . This interview involve thorough diagnostic interview ask different psychological feeling It also involve several rating scale ask depression , anxiety , obsessive compulsive disorder ( OCD ) , suicidality . The following scale conduct visit : Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders-IV ( DSM ) ( SCID-I ) clinician-administered , semi-structured diagnostic interview mental health disorder . Hamilton Depression Rating Scale-24 ( HAM-D ) clinician-administered questionnaire design assess severity depression adult . Hamilton Anxiety Rating Scale ( HAM-A ) clinician-administered questionnaire assess severity symptom anxiety . Yale-Brown Obsessive Compulsive Scale ( YBOCS ) clinician administer questionnaire ass severity symptom obsessive compulsive disorder . The Montreal Cognitive Assessment ( MoCA ) clinician administer cognitive screen tool aid detection mild cognitive impairment . The Columbia-Suicide Severity Rating Scale ( C-SSRS ) clinician-administered rating scale quantifies presence severity suicidal ideation behavior . Clinical Global Impression-Severity ( CGI-S ) 7-point clinician rating severity psychopathology . Next , physician conduct brief medical physical exam include : measuring blood pressure , pulse , body weight , current past medical history blood drawn . If female childbearing potential , urine pregnancy test perform . Baseline Visit The result laboratory test perform screen visit review . If eligibility meet , vital sign ( blood pressure , heart rate , weight ) measure . Then member research team ask question current symptom . The following scale conduct visit remain visit study : HAM-D , HAM-A , YBOCS , MoCA , C-SSRS , CGI-S. Clinical Global Impression-Improvement ( CGI-I ) 7-point rating treatment response anchor 1 ( `` much improve ) 7 ( `` much bad '' ) . Blood collect include sample genetic testing . Then first week study drug instruction take give . Please bring unused study drug next visit . Visits 1/End Week 1 , 2/End Week 2 , 3/End Week 4 , 4/End Week 8 , 5/End Week 12 Vital sign measure member research team ask question current symptom . Rating scale conduct assess symptom . Any unused study drug last visit collect count . The study doctor ask overall health wellbeing . Please tell study doctor problem encounter study . The next week 's study drug give . Please bring unused study drug next visit . Additional blood collect visit 5 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Tetrahydrofolates</mesh_term>
	<criteria>Diagnosis Major Depressive Disorder base Structured Clinical Interview DSMIV ( SCID ) Hamilton Depression Rating Scale24 ( HRSD24 ) score 824 . No antidepressant medication past 3 month Pregnancy/Breastfeeding/Reproductive age female use contraception Schizophrenia psychotic disorder Bipolar Disorder Cluster B personality disorder Electroconvulsive Therapy ( ECT ) failure past Concurrent ECT repetitive transcranial magnetic stimulation ( rTMS ) Active substance abuse within past 6 month Use antiepileptic Thyroid Stimulating Hormone ( TSH ) great 4 Untreated Vitamin B12 deficiency ( Vitamin B12 le 400 ) Neurodegenerative disease dementia ( Mini Mental Status Examination ( MMSE ) less equal 24 ) Suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>MTHFR</keyword>
	<keyword>L-methylfolate</keyword>
</DOC>